Home | Links | Contact Us | More About Intellectual Property | Bookmark
Search patents:
Home Gene Therapy Diagnostic-probes-for-pneumocystis-carini

 Cryptophycins
OF THE INVENTION The present invention provides novel cryptophycin compounds having the following ...


 Method for recovery of refined .alpha.-galactosidase
OF THE INVENTION The methods heretofore suggested for the refinement of .alpha.-galactosidase ...


 Antimicrobial composition containing Type II endoglycosidase and antimicrobial agent
The invention provides antimicrobial methods utilizing Type II endoglycosidases such as endo-.beta.-...


 Wound healing composition of IGF-I and TGF-.beta.
We claim: 1. A method for healing an external wound of a mammal comprising applying to said wound a ...


 Flowable demineralized bone powder composition and its use in bone repair
What is claimed is: 1. A flowable composition for application to a bone defect site to promote new ...


 Crosslinkable polypeptide compositions
OF THE INVENTION In accordance with the present invention, there are provided chemically modified ...


 Diagnostic probes for pneumocystis carini

Details
Inventors: Leibowitz, Michael J.; Liu, Yong;
Assignee: University of Medicine & Dentistry of New Jersey (Newark, NJ)
Primary Examiner: Myers; Carla J.
Assistant Examiner:
Attorney, Agent or Firm: Muccino; Richard R.

The present invention pertains to a method for diagnosing for Pneumocystis carinii by detecting the presence of a nucleic acid sequence containing the 26S rRNA gene specific for Pneumocystis carinii. More particularly, this invention relates to a method for diagnosing for Pneumocystis carinii which comprises amplifying a sample of DNA from Pneumocystis carinii by polymerase chain reaction (PCR) using species specific primers and detecting the PCR products with species specific radioactive or non-radioactive oligonucleotide probes. This invention also relates to a method for diagnosing for various species of Pneumocystis carinii by detecting the presence of a nucleic acid sequence containing the particular 16S or 26S rRNA gene sequence specific for that species of Pneumocystis carinii.

DETAILED DESCRIPTION OF THE INVENTION This invention relates to a method for diagnosing for Pneumocystis carinii by detecting the presence of a nucleic acid sequence containing the 26S rRNA gene specific for Pneumocystis carinii.
More particularly, this invention relates to a method for diagnosing for Pneumocystis carinii which comprises amplifying a sample of DNA from Pneumocystis carinii by polymerase chain reaction (PCR) using species specific primers and detecting the PCR products with species specific radioactive or non-radioactive oligonucleotide probes.
This invention also relates to a method for diagnosing for various species of Pneumocystis carinii by detecting the presence of a nucleic acid sequence containing the particular 16S or 26S rRNA gene sequence specific for that species of Pneumocystis carinii.
The term "oligonucleotide" as used herein refers to primers, probes, oligomer fragments to be detected, oligomer controls, and unlabeled blocking oligomers.
Oligonucleotide are molecules comprised of two or more deoxyribonucleotides or ribonucleotides.
The term "primer" as used herein refers to an oligonucleotide, preferably an oligodeoxyribonucleotide, either naturally occurring such as a purified restriction digest or synthetically produced, which is capable of acting as a point of initiation of synthesis when subjected to conditions in which synthesis of a primer extension product, which is complementary to a nucleic acid strand, is induced, i.
e.
, in the presence of nucleotides, an agent for polymerization such as a DNA polymerase, and a suitable temperature and pH.
The primer must be sufficiently long to prime the synthesis of extension products in the presence of the polymerization agent.
In accord with the method of the present invention, the sequence of the portion of the major rRNA-encoding operon (encoding the 16S, 5.
8S and 26S rRNA molecules specific for P.
carinii) from organisms derived from the lungs of immunosuppressed rats, including the genes for 5.
8S and 26S rRNAs, has been determined



Related patents
  Peanut allergens and methods
OF THE INVENTION In accordance with a preferred embodiment of the present invention, a monoclonal antibody (MAb) based enzyme-linked immunosorbent assay (ELISA) and ...
  Method for sequencing DNA using biotin-strepavidin conjugates to facilitate the purification of primer extension products
OF THE INVENTION Applicants' invention provides a simplified method for isolating primer extension products from template-directed DNA polymerase reactions. For the ...
  Comparative genomic hybridization (CGH)
Comparative Genomic Hybridization (CGH) has also been termed Copy Ratio Reverse Cytogenetics (CRRC), competition hybridization and quantitative in situ ratio ...
  DNA sequence-based HLA typing method
The present invention relates to a method for determining the nucleic acid sequence of one or more polymorphic genes of a subject by amplifying and direct sequencing ...
  Alterations in the long QT syndrome genes KVLQT1 and SCN5A and methods for detecting same
OF THE INVENTION The present invention relates to alterations in the KVLQT1, HERG, SCN5A, KCNE1 and KCNE2 genes and methods for detecting such alterations. The ...
  Method for forming image
OF THE INVENTION In accordance with the present invention there is provided a method for processing a silver halide color photographic material that has silver halide ...
  WF11243 substance
We claim: 1. An isolated compound having formula (I): ##STR4## or a salt thereof. 2. A method for producing a compound of formula (I): ##STR5## or a salt thereof which ...
  Plant virus vector, plasmid, process for expression of foreign gene and process for obtaining foreign gene product
The purpose of the present invention is to provide plant virus vectors having the ability to systemically infect a whole plant; plasmids, which are transcribed to ...
  Electrophoretic method for the isolation and separation of microorganisms and cell populations
It is an object of the invention to provide a novel electrophoretic method for the separation of viable mixtures of viable bacteria for analysis of microbial communities....
  Human antithrombin III
The present invention is directed to the means and methods of producting human antithrombin III via recombinant DNA technology, including (1) the discovery and identity ...

0.014

Archive: All patents - Links

Copyright (c)2006 Eipa-patents.org - All rights reserved